Thermo Fisher Scientific Other Investing increased by 92.9% to -$1.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2022 to FY 2025), Other Investing shows an upward trend with a -53.9% CAGR.
Usually represents minor adjustments; however, large values should be scrutinized for one-time asset disposals or unusual investment activities.
A category capturing miscellaneous cash flows from investing activities that do not fall under capital expenditures, acq...
Standard across most corporate cash flow statements as a balancing category for non-core investing movements.
cf_other_investing| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $2.00M | -$8.00M | -$75.00M | $3.00M | -$19.00M | -$14.00M | $116.00M | $6.00M | $52.00M | -$7.00M | -$5.00M | -$2.00M | -$1.00M | -$5.00M | -$14.00M | -$1.00M |
| QoQ Change | — | -50.0% | -500.0% | -837.5% | +104.0% | -733.3% | +26.3% | +928.6% | -94.8% | +766.7% | -113.5% | +28.6% | +60.0% | +50.0% | -400.0% | -180.0% | +92.9% |
| YoY Change | — | — | — | <-999% | +50.0% | — | -75.0% | +254.7% | +100.0% | +373.7% | +50.0% | -104.3% | -133.3% | +85.7% | +0.0% | -600.0% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.